Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

2024 Year in Review: Neuro-oncology Focus: Glioblastoma Trials

Soma Sengupta

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

2025 Update on IDH-Mutant Gliomas

Jan Drappatz

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Delayed Diagnosis and Diagnostic Imprinting in Pediatric CNS Tumors:…

Ibrahim Qaddoumi

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Bagley

IDH-Mutant Diffuse Glioma: Best Practices for Multidisciplinary Appr…

Ruham Nasany

2024 Neuro-Oncology Update: Brain Tumors

Scripps Health

T. McGranahan

Overview of CNS Cancers

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

V. Venur

Overview and Updates in Brain Tumors

Henry Friedman

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

Vorasidenib for Low Grade Gliomas

Stanford Medicine

T. Cao

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

BRAF/MEK Targeted Therapy in Adult and Pediatric Glioma: Insights an…

Johns Hopkins

K. Schreck

Best Practices for the Provider Approach in Treating Patients With I…

Katherine Peters

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

S. Mohan

Clinical Implications of the Updated Efficacy Results of the INDIGO …

Riccardo Soffietti

Diffuse Glioma: A Serious and Under-Recognized Mimic of Inflammatory…

OHSU

J. Perlman

Diagnosing IDH-Mutant Diffuse Glioma: Recent Classification Updates …

Ashley Aaroe